Prof. Dr. Cihan Uras

Comparison of Tailor X and NSABP-20 regarding cost-effectiveness of recurrence score (RS®) for adjuvant chemotherapy decision in early-stage breast cancer

BMC Health Services Research, 2026

DOI 10.1186/s12913-026-15300-9 Source : OpenAlex

Absence of high-risk human papillomavirus in breast cancer tissues from young BRCA1/BRCA2-negative women

BMC Women s Health, 2026

DOI 10.1186/s12905-026-04494-z PMID 42057021 Texte intégral en libre accèsSource : OpenAlex

Evolving Concepts and Contemporary Management of Early-Stage Breast Cancer: An Evidence-Based Approach to Grey Zones from a Comprehensive Breast Unit Part 1: Locoregional Therapy, Pathology, Radiology

European Journal of Breast Health, 2026

DOI 10.4274/ejbh.galenos.2026.2025-10-1 PMID 41873792 Texte intégral en libre accèsSource : OpenAlex

Effect of Primary Breast Surgery on Prognosis in Breast Cancer Patients Presenting with Isolated Bone Metastases

Cancers, 2026

DOI 10.3390/cancers18111760 PMID 42279343 Texte intégral en libre accèsSource : OpenAlex

Effect of Manual Lymph Drainage on Breast Edema After Breast-Conserving Surgery and Radiotherapy: A Preliminary Randomized Controlled Trial

Cancers, 2026

DOI 10.3390/cancers18101510 PMID 42192872 Texte intégral en libre accèsSource : OpenAlex

Concordance Between AI-generated Recommendations and Multidisciplinary Tumor Board Decisions in Postoperative Breast Cancer Management: A Retrospective Validation Study

Turkish Journal of Surgical Oncology, 2026

DOI 10.4274/turkjsurgoncol.galenos.2026.69885 Texte intégral en libre accèsSource : OpenAlex

Concomitant Cholecystectomy During Bariatric Surgery: Surgical Technique and Safety

Journal of Laparoendoscopic & Advanced Surgical Techniques, 2026

DOI 10.1177/10926429261491052 PMID 42802608 Source : OpenAlex

Survival of the Patients With Breast Cancer Who Underwent Oncotype DX Recurrence Score Testing: Long‐Term Survival Update of a Prospective Multicenter Study in Türkiye According to Different Cut‐Offs

World Journal of Surgery, 2025

DOI 10.1002/wjs.70025 PMID 40751287 Source : OpenAlex

Association of Mitochondrial DNA Copy Number Variations with Triple-Negative Breast Cancer: A Potential Biomarker Study

Diseases, 2025

DOI 10.3390/diseases13060175 PMID 40558586 1 citation (Europe PMC) Texte intégral en libre accèsSource : OpenAlex

De-Escalation of Nodal Surgery in Clinically Node-Positive Breast Cancer

JAMA Surgery, 2025

DOI 10.1001/jamasurg.2024.5913 PMID 39745737 28 citations (Europe PMC) Texte intégral en libre accèsSource : OpenAlex

Locoregional Treatment in De Novo Bone-Only Metastatic Breast Cancer: Prospective, Multi-Institutional Real-World Data, BOMETIN, Protocol MF14-1a

Current Oncology, 2025

DOI 10.3390/curroncol32100556 PMID 41149476 2 citations (Europe PMC) Texte intégral en libre accèsSource : OpenAlex

ASO Visual Abstract: Breast Cancer Recurrence in Initially Clinically Node-Positive Patients Undergoing Sentinel Lymph Node Biopsy after Neoadjuvant Chemotherapy in the NEOSENTITURK-trials MF18-02/18-03

Annals of Surgical Oncology, 2025

DOI 10.1245/s10434-024-16746-z PMID 39964563 Source : OpenAlex

Comparison of Clinicopathologic Features and Survival Outcomes of Pleomorphic Lobular, Classical Lobular, and Invasive Ductal Carcinoma

World Journal of Surgery, 2025

DOI 10.1002/wjs.12589 PMID 40252206 Source : OpenAlex

Axillary dissection for low-volume nodal involvement after neoadjuvant therapy in breast cancer: multicentre AXSANA cohort study

British journal of surgery, 2025

DOI 10.1093/bjs/znaf180 PMID 40966675 1 citation (Europe PMC) Source : OpenAlex

Omission of axillary dissection after neoadjuvant systemic treatment in initially node-positive HER2-overexpressed and triple-negative breast cancer patients: SENATURK OTHER-NAC study

European Journal of Surgical Oncology, 2025

DOI 10.1016/j.ejso.2025.109642 PMID 40009910 5 citations (Europe PMC) Source : OpenAlex

Omitting Axillary Dissection in Triple-Negative and HER2-Overexpressed Breast Cancers With Positive Sentinel Lymph Nodes During Upfront Surgery: SENATURK-OTHELLO Study

Clinical Breast Cancer, 2025

DOI 10.1016/j.clbc.2025.02.002 PMID 40055044 1 citation (Europe PMC) Source : OpenAlex

Relationships Between Breast Edema and Axillary Lymph Node Metastasis in Breast Cancer

Diagnostics, 2025

DOI 10.3390/diagnostics15111300 PMID 40506872 2 citations (Europe PMC) Texte intégral en libre accèsSource : OpenAlex

Causes of diagnostic and treatment delays in locally advanced breast cancer: a nationwide multicenter survey and electronic health records analysis in Turkiye

European Journal of Public Health, 2025

DOI 10.1093/eurpub/ckaf108 PMID 40628383 2 citations (Europe PMC) Texte intégral en libre accèsSource : OpenAlex

Comparison of Early Results of Laparoscopic Transabdominal Preperitoneal and Total Extraperitoneal Repair in Recurrent Inguinal Hernia

Journal of Laparoendoscopic & Advanced Surgical Techniques, 2025

DOI 10.1089/lap.2025.0067 PMID 40495725 1 citation (Europe PMC) Source : OpenAlex

Poor Prognostic Clinicopathological Features of Young Women with Breast Cancer in the MF18-04 Turkish National Breast Cancer Registry Study

Asian Pacific Journal of Cancer Prevention, 2025

DOI 10.31557/apjcp.2025.26.12.4407 PMID 41459855 Texte intégral en libre accèsSource : OpenAlex

P044: Examining the Correlation and Concordance Between Ki-67 Expression and Oncotype DX Recurrence Score: Findings from a Multicenter Study in Turkey

The Breast, 2025

DOI 10.1016/j.breast.2025.103928 1 citation (OpenAlex) Texte intégral en libre accèsSource : OpenAlex

Abstract P2-03-14: PATIENT REPORTED OUTCOMES AND LYMPHEDEMA IN NODE-POSITIVE BREAST CANCER IN THE EARLY POSTOPERATIVE PERIOD AFTER NEOADJUVANT CHEMOTHERAPY IN THE PROSPECTIVE NEOSENTITURK-trial MF18-03

Clinical Cancer Research, 2025

DOI 10.1158/1557-3265.sabcs24-p2-03-14 Source : OpenAlex

Abstract P4-06-06: The Etiologic Causes of Diagnostic Delay in Locally Advanced Breast Cancer: _x000B_A Multicentric Nationwide Trial

Clinical Cancer Research, 2025

DOI 10.1158/1557-3265.sabcs24-p4-06-06 Source : OpenAlex

Abstract P3-07-10: Omitting axillary dissection in Triple-negative and HER2-overexpressed cancers After neoadjuvant Chemotherapy: OTHER-NAC Study

Clinical Cancer Research, 2025

DOI 10.1158/1557-3265.sabcs24-p3-07-10 Source : OpenAlex

Abstract P3-07-14: Omitting axillary dissection in Triple-negative and HER2-overexpressed breast cancers with positive sentinel Lymph nOdes during upfront surgery: OTHELLO Study

Clinical Cancer Research, 2025

DOI 10.1158/1557-3265.sabcs24-p3-07-14 Source : OpenAlex

Utilization of Serratus Muscle-Fascia Flap to Ensure Implant Stability in Prepectoral Direct-to-Implant Reconstruction

Aesthetic Plastic Surgery, 2025

DOI 10.1007/s00266-025-05238-4 PMID 41023234 Source : OpenAlex

Positive anti-TG antibody is associated with increased breast cancer risk in Turkish peri-postmenopausal women: A retrospective study

Research Square, 2024

DOI 10.21203/rs.3.rs-4673282/v1 Texte intégral en libre accèsSource : OpenAlex

Combined analysis of the MF18‐02/MF18‐03 NEOSENTITURK studies: ypN‐positive disease does not necessitate axillary lymph node dissection in patients with breast cancer with a good response to neoadjuvant chemotherapy as long as radiotherapy is provided

Cancer, 2024

DOI 10.1002/cncr.35610 PMID 39476303 13 citations (Europe PMC) Texte intégral en libre accèsSource : OpenAlex

Breast Cancer Recurrence in Initially Clinically Node-Positive Patients Undergoing Sentinel Lymph Node Biopsy After Neoadjuvant Chemotherapy in the NEOSENTITURK-Trials MF18-02/18-03

Annals of Surgical Oncology, 2024

DOI 10.1245/s10434-024-16472-6 PMID 39623189 8 citations (Europe PMC) Texte intégral en libre accèsSource : OpenAlex

Abstract PS01-01: Feasibility and oncological safety of targeted axillary dissection or sentinel lymph node biopsy in patients with clinically node-positive disease after neoadjuvant chemotherapy in the prospective MF-1803 NEOSENTITURK-study

Cancer Research, 2024

DOI 10.1158/1538-7445.sabcs23-ps01-01 2 citations (OpenAlex) Texte intégral en libre accèsSource : OpenAlex

Abstract PO5-05-12: Loco-regional Treatment in De Novo Bone Only Metastatic Breast Cancer; Prospective, Multi-Institutional Real-World Data, BOMETIN, Protocol MF14-1a

Cancer Research, 2024

DOI 10.1158/1538-7445.sabcs23-po5-05-12 Source : OpenAlex

Nodal Burden and Oncologic Outcomes in Patients With Residual Isolated Tumor Cells After Neoadjuvant Chemotherapy (ypN0i+): The OPBC-05/ICARO Study

Journal of Clinical Oncology, 2024

DOI 10.1200/jco.24.01052 PMID 39509672 44 citations (Europe PMC) Texte intégral en libre accèsSource : OpenAlex

Kinesiophobia, physical activity levels and barriers in breast cancer patients, survivors, and healthy controls: a case-control analysis

Journal of the Pakistan Medical Association, 2024

DOI 10.47391/jpma.10558 PMID 39160708 4 citations (Europe PMC) Source : OpenAlex

ASO Author Reflections: Nodal Recurrence Is Rare in Patients with cN+/ycN0 Breast Cancer after Neoadjuvant Chemotherapy Regardless of the Extent of Axillary Surgery or Nodal Pathology in the NEOSENTITURK-Trials MF18-02/18-03 Provided Regional Nodal Irradiation Is Administered

Annals of Surgical Oncology, 2024

DOI 10.1245/s10434-024-16651-5 PMID 39653946 1 citation (Europe PMC) Source : OpenAlex

A New Convenient Incision Model of the Nipple-Sparing Mastectomy: Lateralized Parabolic Multiplanar Incision

Aesthetic Plastic Surgery, 2024

DOI 10.1007/s00266-024-04115-w PMID 38769149 1 citation (Europe PMC) Source : OpenAlex

Unmet Needs of Breast Cancer Survivors and Related Factors: A Cross-Sectional Study

Research Square, 2024

DOI 10.21203/rs.3.rs-5379884/v1 1 citation (Europe PMC) Texte intégral en libre accèsSource : OpenAlex

Abstract PO1-22-03: Radiation Toxicity and Treatment Outcomes in Breast Cancer Patients with ATM Pathogenic and VUS Mutations: Implications for Personalized Therapy

Cancer Research, 2024

DOI 10.1158/1538-7445.sabcs23-po1-22-03 Source : OpenAlex

What Do Breast Cancer Previvors Tell Us About Their Stories? To Know or Not to Know?

Seminars in Oncology Nursing, 2024

DOI 10.1016/j.soncn.2024.151714 PMID 39164159 Source : OpenAlex

Survival results according to Oncotype Dx recurrence score in patients with hormone receptor positive HER-2 negative early-stage breast cancer: first multicenter Oncotype Dx recurrence score survival data of Turkey

Frontiers in Oncology, 2023

DOI 10.3389/fonc.2023.1151733 PMID 37448522 8 citations (Europe PMC) Texte intégral en libre accèsSource : OpenAlex

Assessment High-Risk Breast Cancer in Older Patients: A Comparative Analysis of PREDICT Scores and TAILORx Risk Categorization

European Journal of Breast Health, 2023

DOI 10.4274/ejbh.galenos.2023.2023-8-5 PMID 37795003 Texte intégral en libre accèsSource : OpenAlex

Abstract P2-11-31: FAVORABLE LOCOREGIONAL CONTROL IN CLINICALLY NODE-NEGATIVE HORMONE-RECEPTOR POSITIVE BREAST CANCER WITH LOW 21-GENE RECURRENCE SCORES: A SINGLE INSTITUTIONAL STUDY WITH 10-YEAR FOLLOW-UP

Cancer Research, 2023

DOI 10.1158/1538-7445.sabcs22-p2-11-31 1 citation (OpenAlex) Source : OpenAlex

False-positive MRI Findings in Breast Cancer After Neoadjuvant Chemotherapy and Correlation Between Tumor Response Patterns and HER2 Status

Acta Oncologica Turcica, 2023

DOI 10.5505/aot.2023.60973 Source : OpenAlex

Abstract PD15-01: PD15-01 AXILLARY NODAL RECURRENCE IS RARE IN PATIENTS WITH NODE-POSITIVE BREAST CANCER UNDERGOING SLNB FOLLOWING NEOADJUVANT CHEMOTHERAPY : EARLY RESULTS OF THE NEOSENTITURK-TRIAL/MF-18-03

Cancer Research, 2023

DOI 10.1158/1538-7445.sabcs22-pd15-01 Texte intégral en libre accèsSource : OpenAlex

Local steroid injection in severe idiopathic granulomatous mastitis as a new first-line treatment modality with promising therapeutic efficacy

Frontiers in Medicine, 2023

DOI 10.3389/fmed.2023.1251851 PMID 37859855 8 citations (Europe PMC) Texte intégral en libre accèsSource : OpenAlex

Sentinel lymph node biopsy after nipple-sparing mastectomy in early postoperative period: Is it feasible?

Indian Journal of Cancer, 2023

DOI 10.4103/ijc.ijc_1175_20 PMID 37530247 2 citations (Europe PMC) Source : OpenAlex

Direct to Implant versus 2-Stage Expander Implant Immediate Breast Reconstruction: Comparison of Incidence and Predictors of Complications

Acibadem Universitesi Saglik Bilimleri Dergisi, 2023

DOI 10.31067/acusaglik.1291793 Source : OpenAlex

Adherence to adjuvant tamoxifen and associated factors in breast cancer survivors

Supportive Care in Cancer, 2023

DOI 10.1007/s00520-023-07742-2 PMID 37079089 5 citations (Europe PMC) Texte intégral en libre accèsSource : OpenAlex

Implant selection in natural and stable direct-to-implant reconstruction with ten steps at nipple-sparing mastectomy

Medicine, 2023

DOI 10.1097/md.0000000000033758 PMID 37171305 2 citations (Europe PMC) Texte intégral en libre accèsSource : OpenAlex

Turkish Validity and Reliability Study of Breast Cancer Self-Efficacy Survivor Scale

Gümüşhane Üniversitesi Sağlık Bilimleri Dergisi, 2023

DOI 10.37989/gumussagbil.1320681 Source : OpenAlex

Comparison of mammography and ultrasound findings in the follow-up of patients with breast cancer treated with segmental mastectomy followed by intraoperative electron radiotherapy versus external whole breast radiotherapy

Diagnostic and Interventional Radiology, 2023

DOI 10.4274/dir.2023.211218 PMID 36994946 Texte intégral en libre accèsSource : OpenAlex